BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14644666)

  • 1. OECD validation of the Hershberger assay in Japan: phase 2 dose response of methyltestosterone, vinclozolin, and p,p'-DDE.
    Yamasaki K; Sawaki M; Ohta R; Okuda H; Katayama S; Yamada T; Ohta T; Kosaka T; Owens W
    Environ Health Perspect; 2003 Dec; 111(16):1912-9. PubMed ID: 14644666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p'-DDE in rodent 10-day Hershberger assay.
    Kang IH; Kim HS; Shin JH; Kim TS; Moon HJ; Kim IY; Choi KS; Kil KS; Park YI; Dong MS; Han SY
    Toxicology; 2004 Jul; 199(2-3):145-59. PubMed ID: 15147789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OECD validation of the Hershberger assay in Japan: Phase 3. Blind study using coded chemicals.
    Yamasaki K; Ohta R; Okuda H
    Toxicol Lett; 2006 May; 163(2):121-9. PubMed ID: 16289407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies.
    Owens W; Gray LE; Zeiger E; Walker M; Yamasaki K; Ashby J; Jacob E
    Environ Health Perspect; 2007 May; 115(5):671-8. PubMed ID: 17520051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
    Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
    Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OECD validation of the rodent Hershberger assay using three reference chemicals; 17alpha-methyltestosterone, procymidone, and p,p'-DDE.
    Shin JH; Moon HJ; Kang IH; Kim TS; Lee SJ; Ahn JY; Bae H; Jeung EB; Han SY
    Arch Toxicol; 2007 May; 81(5):309-18. PubMed ID: 17216431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of estrogenic or (anti-)androgenic effects of d-phenothrin in the uterotrophic and Hershberger assays.
    Yamada T; Ueda S; Yoshioka K; Kawamura S; Seki T; Okuno Y; Mikami N
    Toxicology; 2003 Apr; 186(3):227-39. PubMed ID: 12628315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a 5-day Hershberger assay using young mature male rats: methyltestosterone and p,p'-DDE, but not fenitrothion, exhibited androgenic or antiandrogenic activity in vivo.
    Sunami O; Kunimatsu T; Yamada T; Yabushita S; Sukata T; Miyata K; Kamita Y; Okuno Y; Seki T; Nakatsuka I; Matsuo M
    J Toxicol Sci; 2000 Dec; 25(5):403-15. PubMed ID: 11201171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced rat Hershberger assay appears reliable for detection of not only (anti-)androgenic chemicals but also thyroid hormone modulators.
    Yamada T; Kunimatsu T; Miyata K; Yabushita S; Sukata T; Kawamura S; Seki T; Okuno Y; Mikami N
    Toxicol Sci; 2004 May; 79(1):64-74. PubMed ID: 14976338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OECD validation of phase 3 Hershberger assay in Korea using surgically castrated male rats with coded chemicals.
    Moon HJ; Kang TS; Kim TS; Kang IH; Ki HY; Kim SH; Han SY
    J Appl Toxicol; 2009 May; 29(4):350-5. PubMed ID: 19241440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissection and weighing of accessory sex glands after formalin fixation, and a 5-day assay using young mature rats are reliable and feasible in the Hershberger assay.
    Yamada T; Sunami O; Kunimatsu T; Kamita Y; Okuno Y; Seki T; Nakatsuka I; Matsuo M
    Toxicology; 2001 May; 162(2):103-19. PubMed ID: 11337110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses. Phase 1: use of a potent agonist and a potent antagonist to test the standardized protocol.
    Owens W; Zeiger E; Walker M; Ashby J; Onyon L; Gray LE
    Environ Health Perspect; 2006 Aug; 114(8):1259-65. PubMed ID: 16882536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the rodent Hershberger bioassay on intact juvenile males--testing of coded chemicals and supplementary biochemical investigations.
    Freyberger A; Schladt L
    Toxicology; 2009 Aug; 262(2):114-20. PubMed ID: 19467291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antiandrogenic effects of flutamide, DDE, and linuron in the weanling rat assay using organ weight, histopathological, and proteomic approaches.
    Tinwell H; Friry-Santini C; Rouquié D; Belluco S; Elies L; Pallen C; Bars R
    Toxicol Sci; 2007 Nov; 100(1):54-65. PubMed ID: 17686919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the environmental antiandrogen p,p-DDE in CD and long-evans rats using a tier I screening battery and a Hershberger assay.
    O'Connor JC; Frame SR; Davis LG; Cook JC
    Toxicol Sci; 1999 Sep; 51(1):44-53. PubMed ID: 10496676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of (anti-) androgenic or estrogenic effects of three pyrethroids (esfenvalerate, fenvalerate, and permethrin) in the Hershberger and uterotrophic assays.
    Kunimatsu T; Yamada T; Ose K; Sunami O; Kamita Y; Okuno Y; Seki T; Nakatsuka I
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):227-37. PubMed ID: 12052007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OECD validation of phase-3 Hershberger assay using the stimulated weanling male rat in Korea.
    Moon HJ; Kang TS; Kim TS; Kang IH; Kim SH; Han SY
    J Appl Toxicol; 2010 May; 30(4):361-8. PubMed ID: 20082360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concept evaluation: androgen-stimulated immature intact male rats as an assay for antiandrogens.
    Ashby J; Owens W; Lefevre PA
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):280-5. PubMed ID: 12052012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the rodent Hershberger bioassay using three reference (anti)androgens.
    Freyberger A; Hartmann E; Krötlinger F
    Arh Hig Rada Toksikol; 2005 Jun; 56(2):131-9. PubMed ID: 15968828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
    Kelce WR; Lambright CR; Gray LE; Roberts KP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.